Advanced search
Publication Cover
Breast Cancer: Targets and Therapy Volume 8, 2016 - Issue
Submit an article Journal homepage
74
Views
2
CrossRef citations to date
0
Altmetric
Letter

Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al

Antonio Ieni1 Department of Human Pathology of Adult and Evolutive Age “Gaetano Barresi”, Section of Pathology, University of Messina, AOU “Policlinico G Martino”
,
Valeria Barresi1 Department of Human Pathology of Adult and Evolutive Age “Gaetano Barresi”, Section of Pathology, University of Messina, AOU “Policlinico G Martino”
,
Giuseppina Rosaria Rita Ricciardi2 Medical Oncology Unit AOOR Papardo-Piemonte, Department of Human Pathology of Adult And Evolutive Age “Gaetano Barresi”, University of Messina, Messina, Italy
,
Barbara Adamo3 Medical Oncology Hospital Clinic, Barcelona, Spain
,
Vincenzo Adamo2 Medical Oncology Unit AOOR Papardo-Piemonte, Department of Human Pathology of Adult And Evolutive Age “Gaetano Barresi”, University of Messina, Messina, Italy
&
Giovanni Tuccari1 Department of Human Pathology of Adult and Evolutive Age “Gaetano Barresi”, Section of Pathology, University of Messina, AOU “Policlinico G Martino”Correspondence[email protected]
Pages 157-159 | Published online: 19 Aug 2016

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Stella K. Vasiliou & Eleftherios P. Diamandis. (2019) Androgen receptor: A promising therapeutic target in breast cancer. Critical Reviews in Clinical Laboratory Sciences 56:3, pages 200-223.
Read now

Articles from other publishers (1)

Jan Dominik Kuhlmann, Hagen Sjard Bachmann, Theresa Link, Pauline Wimberger, Eric Kröber, Christoph Thomssen, Brahima Mallé, Daniel Bethmann, Martina Vetter & Eva Johanna Kantelhardt. (2019) Association of caspase 8 polymorphisms -652 6N InsDel and Asp302His with progression-free survival and tumor infiltrating lymphocytes in early breast cancer. Scientific Reports 9:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.